Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemia

Bone Marrow Transplant. 2020 Feb;55(2):473-475. doi: 10.1038/s41409-019-0553-x. Epub 2019 May 14.

Authors

Ibrahim Aldoss¹, Ryotaro Nakamura², Dongyun Yang³, Amandeep Salhotra², Anthony S Stein², Vinod Pullarkat², Stephen J Forman², Guido Marcucci²

Affiliations

¹ Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA. ialdoss@coh.org.
² Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.
³ Department of Computational & Quantitative Medicine, City of Hope, Duarte, CA, USA.

PMID: 31089274
DOI: 10.1038/s41409-019-0553-x

No abstract available

Publication types

Letter

MeSH terms

Aged
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myeloid, Acute* / therapy
Mutation
Nuclear Proteins / genetics
Nucleophosmin
Prognosis
fms-Like Tyrosine Kinase 3 / genetics

Substances

NPM1 protein, human
Nuclear Proteins
Nucleophosmin
FLT3 protein, human
fms-Like Tyrosine Kinase 3